Center for Breakthrough Medicines
King Of Prussia
About Center for Breakthrough Medicines
Center for Breakthrough Medicines is an innovative cell and gene therapy focusing on contract development and manufacturing organization.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $350.0M
- Funding stage: M&A
- Last round: Corporate Round (Jan 2022)
- Website: breakthroughmedicines.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Genetics, Manufacturing, Medical
Social Profiles
Canonical: https://fsome.com/organization/center-for-breakthrough-medicines-76902 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.